🔗 Permalink

Assignee profile:

60 Degrees Pharmaceuticals, LLC

City:

Washington, District of Columbia

Country:

United States

Published Applications:

Last publication date:

2025-03-06

Patent Grants:

Last grant date:

2025-08-12

Top Inventors for applications by 60 Degrees Pharmaceuticals, LLC

These are the the leading inventors for applications assigned to 60 Degrees Pharmaceuticals, LLC:

Geoffrey S. DOW 16 Washington, DC United States
Bryan L Smith 7 Chevy Chase, MD United States
Moshe Shmuklarsky 4 Bethesda, MD United States
Eng Eong Ooi 4 Singapore, Singapore

John P. Jones 4 Richmond, VA United States
Budda Balasubrahmanyam 4 Richmond, VA United States
Satoru WATANABE 4 Singapore, Singapore
Subhash VASUDEVAN 4 Singapore, Singapore

Jenny LOW 4 Singapore, Singapore
Abhay RATHORE 3 Singapore, Singapore
Mark Reid 3 Toowong, Australia
Cynthia SUNG 3 Singapore, Singapore

Glynn Morrish 3 Toowong, Australia
Edouard Vannier 2 Boston, MA United States
Glynn MORRISH 1 Toowong, Queensland, Australia
John Paul Jones 1 Richmond, VA United States

Mark REID 1 Toowong, Queensland, Australia
Geoffrey S. Dow 1 , DC United States
Peter J. Krause 1 New Haven, CT United States
Kitti Wing Ki Chan 1 Singapore, Singapore

Recent patent applications by 60 Degrees Pharmaceuticals, LLC

60 Degrees Pharmaceuticals, LLC based in Washington, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-03-06

US20250073222A1

Human necessities

METHODS FOR THE TREATMENT AND PREVENTION OF NON-VIRAL TICK-BORNE DISEASES AND SYMPTOMS THEREOF

#2 | 2024-12-12

US20240408074A1

Human necessities

METHODS FOR THE TREATMENT AND PREVENTION OF NON-VIRAL TICK-BORNE DISEASES AND SYMPTOMS THEREOF OF

#3 | 2024-11-28

US20240390359A1

Human necessities

METHODS FOR THE TREATMENT AND PREVENTION OF NON-VIRAL TICK-BORNE DISEASES AND SYMPTOMS THEREOF

#4 | 2024-07-11

US20240226087A9

Human necessities

METHODS FOR THE TREATMENT AND PREVENTION OF LUNG INFECTIONS CAUSED BY GRAM-POSITIVE BACTERIA, FUNGUS, OR VIRUS BY ADMINISTRATION OF TAFENOQUINE

#5 | 2024-05-23

US20240165099A1

Human necessities

METHODS FOR THE TREATMENT AND PREVENTION OF DISEASES OR INFECTIONS WITH MCP-1 INVOLVEMENT BY ADMINISTRATION OF TAFENOQUINE

#6 | 2024-04-25

US20240131019A1

Human necessities

METHODS FOR THE TREATMENT AND PREVENTION OF LUNG INFECTIONS CAUSED BY GRAM-POSITIVE BACTERIA, FUNGUS, OR VIRUS BY ADMINISTRATION OF TAFENOQUINE

#7 | 2024-03-14

US20240082233A1

Human necessities

Regimens of Tafenoquine for Prevention of Malaria in Malaria-Naive Subjects

#8 | 2023-01-19 ✅ Patent 12,383,546 granted on 2025-08-12

US20230018428A1

Human necessities

METHODS FOR THE TREATMENT AND PREVENTION OF LUNG INFECTIONS CAUSED BY FUNGUS BY ADMINISTRATION OF TAFENOQUINE

#9 | 2022-12-08

US20220387419A1

Human necessities

METHODS FOR THE TREATMENT AND PREVENTION OF LUNG INFECTIONS CAUSED BY SARS-COV-2 VIRUS BY ADMINISTRATION OF TAFENOQUINE

#10 | 2021-09-02 ✅ Patent 11,633,391 granted on 2023-04-25

US20210267963A1

Human necessities

Methods for the treatment and prevention of lung infections caused by gram-positive bacteria, fungus, or virus by administration of tafenoquine

#11 | 2021-09-02 ✅ Patent 11,744,828 granted on 2023-09-05

US20210267962A1

Human necessities

Regimens of tafenoquine for prevention of malaria in malaria-naïve subjects

#12 | 2020-10-29 ✅ Patent 11,219,616 granted on 2022-01-11

US20200338050A1

Human necessities

Dosing regimens of celgosivir for the treatment of dengue

#13 | 2019-10-31 ✅ Patent 10,888,558 granted on 2021-01-12

US20190328723A1

Human necessities

Regimens of tafenoquine for prevention of malaria in malaria-naive subjects

#14 | 2018-12-20 ✅ Patent 11,000,516 granted on 2021-05-11

US20180360809A1

Human necessities

Dosing regimens of celgosivir for the prevention of dengue

#15 | 2018-03-08 ✅ Patent 10,517,854 granted on 2019-12-31

US20180064693A1

Human necessities

Dosing regiments of celgosivir for the treatment of dengue

#16 | 2017-12-21 ✅ Patent 10,342,791 granted on 2019-07-09

US20170360768A1

Human necessities

Regimens of tafenoquine for prevention of malaria in malaria-naive subjects

#17 | 2016-02-04 ✅ Patent 9,763,921 granted on 2017-09-19

US20160030403A1

Human necessities

Dosing regimens of celgosivir for the treatment of dengue

Also check out 60 Degrees Pharmaceuticals, LLC's (Washington, United States) applicant profile with 16 patent applications submitted.

AssigneeID:

104734 ⎘